|
- Masimo Issues Statement on California Jury Verdict Finding . . .
IRVINE, Calif - Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U S District Court for the Central District of California, which confirmed the validity of Masimo Patent No 10,433,776, found Apple infringed this patent, and awarded Masimo $634 million in damages: “We are pleased by this outcome, and appreciate the time and
- Apple Masimo Lawsuit 2025, $634M Jury Verdict + NEW ITC . . .
A California jury just ordered Apple to pay Masimo $634 million for patent infringement involving blood oxygen technology in Apple Watch, while the U S International Trade Commission simultaneously launched a new investigation on November 14, 2025, to determine whether Apple’s redesigned blood oxygen feature still infringes Masimo’s patents The ITC set a six-month target to complete the
- Apple–Masimo Verdict: Legal Meaning of the $634M Patent Ruling
A California jury’s finding that Apple must pay Masimo $634 million for patent infringement creates an immediate legal moment that turns on how U S law treats medical-grade technologies incorporated into consumer devices From here, the key issues are procedural rather than dramatic Patent
- Apple ordered to pay medtech Masimo $634m for patent . . .
A federal jury has found that Apple owes medtech company Masimo $634m for infringing on its patented blood-oxygen monitoring technology
- Masimo wins $634 million jury verdict in patent fight with Apple
A U S jury ruled on November 15, 2025, that Apple must pay Masimo $634 million in a patent infringement case over smartwatch technology, awarding Masimo a major victory after years of litigation
- Masimo nets $634M patent verdict against Apple as US again . . .
A federal jury in California sided with the patient monitor maker and awarded $634 million in damages—spanning patent claims linked to the Apple Watch’s abnormal heart rate notifications and
- Jury says Apple owes Masimo $634M for patent infringement
A federal jury in California ruled Friday that Apple must pay medical device maker Masimo $634 million for infringing a patent on blood oxygen-monitoring technology Reuters reports the jury
|
|
|